Literature DB >> 26418488

Does the Acute Care Spinal Cord Injury Setting Predict the Occurrence of Pressure Ulcers at Arrival to Intensive Rehabilitation Centers?

Andréane Richard-Denis1, Cynthia Thompson, Étienne Bourassa-Moreau, Stefan Parent, Jean-Marc Mac-Thiong.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the impact of acute care in specialized spinal cord injury (SCI) trauma centers on the prevalence of pressure ulcers (PU) upon arrival at a functional rehabilitation center after a traumatic SCI.
DESIGN: This is a retrospective cohort study among 123 patients with traumatic SCI referred to intensive functional rehabilitation between January 1, 2009, and December 31, 2011. Group 1 (n = 90) was referred from a level 1 specialized SCI trauma center and group 2 (n = 33) was referred from seven trauma centers not specialized in SCI.
RESULTS: The total prevalence of patients with PU at admission to functional rehabilitation was 33.3% (26.7% in group 1 and 51.5% in group 2, P = 0.017). There were also more patients with multiple PU in group 2 (24.2% vs. 2.2%, P = 0.0001). A binary logistic regression showed a significant relationship between the occurrence of PU and the type of acute care facility as well as the ASIA (American Spinal Injury Association) Impairment Scale grade. Receiving acute care at the specialized SCI trauma center was associated with a decrease in the number of patients developing one and multiple PU.
CONCLUSIONS: These results highlight the importance of specialized SCI trauma centers in acute care of patients with traumatic SCI in reducing PU at their admission to functional rehabilitation settings.

Entities:  

Mesh:

Year:  2016        PMID: 26418488     DOI: 10.1097/PHM.0000000000000381

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  7 in total

1.  Effectiveness of a multi-layer foam dressing in preventing sacral pressure ulcers for the early acute care of patients with a traumatic spinal cord injury: comparison with the use of a gel mattress.

Authors:  Andréane Richard-Denis; Cynthia Thompson; Jean-Marc Mac-Thiong
Journal:  Int Wound J       Date:  2017-01-04       Impact factor: 3.315

2.  The impact of acute management on the occurrence of medical complications during the specialized spinal cord injury acute hospitalization following motor-complete cervical spinal cord injury.

Authors:  Andréane Richard-Denis; Debbie Erhmann Feldman; Cynthia Thompson; Jean-Marc Mac-Thiong
Journal:  J Spinal Cord Med       Date:  2017-07-19       Impact factor: 1.985

3.  Development of Tissue Integrity indicators to advance the quality of spinal cord injury rehabilitation: SCI-High Project.

Authors:  Heather Flett; Matheus J Wiest; Vivian Mushahwar; Chester Ho; Jane Hsieh; Farnoosh Farahani; S Mohammad Alavinia; Maryam Omidvar; Pamela E Houghton; B Catharine Craven
Journal:  J Spinal Cord Med       Date:  2019-10       Impact factor: 1.985

4.  The global burden of pressure ulcers among patients with spinal cord injury: a systematic review and meta-analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Henok Mulugeta; Yared Asmare Aynalem
Journal:  BMC Musculoskelet Disord       Date:  2020-05-29       Impact factor: 2.362

5.  Decreasing pressure injuries and acute care length of stay in patients with acute traumatic spinal cord injury.

Authors:  Gabrielle Gour-Provencal; Jean-Marc Mac-Thiong; Debbie E Feldman; Jean Bégin; Andréane Richard-Denis
Journal:  J Spinal Cord Med       Date:  2020-02-11       Impact factor: 1.985

6.  Exploring the first pressure injury and characteristics of subsequent pressure injury accrual following spinal cord injury.

Authors:  Alexandra E Harper; Lauren Terhorst; David Brienza; Natalie E Leland
Journal:  J Spinal Cord Med       Date:  2020-04-01       Impact factor: 1.985

7.  Frequency of turning in bed at home in persons with chronic spinal cord injury.

Authors:  Fatma Eren; Robert DeLuca; Steven Kirshblum
Journal:  J Spinal Cord Med       Date:  2020-08-18       Impact factor: 2.040

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.